Literature DB >> 16887913

Orphanin FQ/nociceptin is a physiological regulator of prolactin secretion in female rats.

Matthew Chesterfield1, James Janik, Emily Murphree, Courtney Lynn, Erin Schmidt, Phyllis Callahan.   

Abstract

Orphanin FQ/nociceptin (OFQ/N), the most recently identified endogenous opioid peptide, stimulates prolactin secretion in both male and female rats. OFQ/N, however, did not elicit this stimulatory effect through the mu-, delta-, or kappa-opiate receptor subtype. The role OFQ/N plays in prolactin regulation under physiological conditions and its mechanism of action are not known. The purpose of these studies was to determine the physiological significance and pharmacological specificity of the prolactin secretory response to OFQ/N. In addition, the role of the tuberoinfundibular dopaminergic (TIDA) neurons in mediating this response was examined. Opioid receptor-like-1 (ORL-1) receptors were blocked by pretreatment with compound B (Comp B), a purported OFQ/N antagonist, or receptor synthesis was disrupted by pretreatment with ORL-1 receptor antisense oligonucleotides. The prolactin secretory response to OFQ/N administration in diestrous females was measured. Furthermore, the suckling-induced prolactin response was also determined after Comp B pretreatment. TIDA neuronal activity was quantified in diestrous female rats to determine whether OFQ/N stimulates prolactin release by inhibiting TIDA neurons. OFQ/N significantly inhibited the TIDA neurons by 1 min, preceding the prolactin secretory response. Both Comp B and antisense pretreatment blocked the stimulatory effects of OFQ/N on prolactin release, and Comp B abolished the suckling-induced prolactin response. These studies indicate that OFQ/N is a potent stimulus for prolactin secretion in female rats and that it mediates this effect by rapid and transient inhibition of TIDA neuronal activity. Furthermore, OFQ/N plays a physiologically significant role in the regulation of prolactin secretion during lactation, and it mediates its effects via actions at the ORL-1 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887913     DOI: 10.1210/en.2006-0707

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 3.  Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2008-09       Impact factor: 3.598

4.  Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation.

Authors:  M Tavakoli-Nezhad; L A Arbogast
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

5.  Diabetes-induced changes in the morphology and nociceptinergic innervation of the rat uterus.

Authors:  Saeed Tariq; Syed M Nurulain; Hameed Rashed; Mohamed Lotfy; Starling Bright Emerald; Surya Koturan; Kornélia Tekes; Ernest Adeghate
Journal:  J Mol Histol       Date:  2015-11-20       Impact factor: 2.611

6.  Central administration of Orphanin FQ inhibits GnRH secretion by ORL1 receptor in the median eminence of freely moving ovariectomized rats.

Authors:  Xiao-Fei An; Ming He; Yi Feng; Hao Feng; Jiang-Yi Yu
Journal:  Neurosci Bull       Date:  2009-02       Impact factor: 5.203

7.  Effects of Pup Separation on Stress Response in Postpartum Female Rats.

Authors:  Manu Kalyani; Phyllis Callahan; James M Janik; Haifei Shi
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.